TP53 and central nervous system cancer: For experiments, we used glioma cells of different sensitivity, as defined in independent studies according to the half maximal inhibitory concentration (IC50) value, O6-methylguanine–DNA methyltransferase (MGMT) expression, wild type p53 expression and phosphatase and tensin homolog (PTEN) deficiency [42,43].